FDA Drug Recalls

Recalls / Class II

Class IID-0944-2018

Product

fentaNYL 3 mcg/mL, 0.1% Bupivacaine, Fentanyl Citrate, USP 750 mcg, Bupivacaine HCL PF, USP, 250 mg, 0.9% Sodium Chloride, USP QS 250 mL. Volume: 250mL. Single dose Cassette. For: Methodist St. John Hospital, By: Advanced Pharma, 9265 Kirby Dr., Houston, TX 77054. NDC 15082-250-87

Affected lot / code info
Lot #: 5/14/18 0913 320-25087Y, BUD 6/28/2018.

Why it was recalled

Lack of Assurance of Sterility: Potential leakage of bags.

Recalling firm

Firm
Avella of Deer Valley, Inc. Store 38
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
24416 N 19th Ave, Phoenix, Arizona 85085-1887

Distribution

Quantity
15 cassettes
Distribution pattern
Nationwide in the USA

Timeline

Recall initiated
2018-06-12
FDA classified
2018-07-19
Posted by FDA
2018-07-25
Terminated
2020-01-24
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0944-2018. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.